0001062993-11-002388.txt : 20110526
0001062993-11-002388.hdr.sgml : 20110526
20110526192113
ACCESSION NUMBER: 0001062993-11-002388
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110524
FILED AS OF DATE: 20110526
DATE AS OF CHANGE: 20110526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Geller Matthew
CENTRAL INDEX KEY: 0001446201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 11875767
MAIL ADDRESS:
STREET 1: 248 CENTRAL PARK WEST
CITY: NEW YORK
STATE: NY
ZIP: 10024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0303
4
2011-05-24
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001446201
Geller Matthew
248 CENTRAL PARK WEST
NEW YORK
NY
10024
1
0
0
0
Common Stock
2011-05-24
4
S
0
7700
24.0831
D
10000
D
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.00 to $24.10. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Matthew Geller by Carl A. Valenstein, attorney in fact
2011-05-26